BRCA2 germline mutations in Swedish breast cancer families

被引:20
|
作者
Chen, JD
Hedman, MZ
Arver, BW
Sigurdsson, S
Eyfjörd, JE
Lindblom, A [1 ]
机构
[1] Karolinska Inst, S-17176 Stockholm, Sweden
[2] Iceland Canc Soc, Mol & Cell Biol Res Lab, Reykjavik, Iceland
关键词
hereditary breast cancer; breast cancer susceptibility gene; BRCA2; cancer family; gene mutation; familial breast cancer; mutations screening;
D O I
10.1038/sj.ejhg.5200167
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Mutations in the breast cancer susceptibility gene (BRCA2) are believed to be responsible for a significant fraction of hereditary breast cancer. To determine the BRCA2 mutation spectrum in a subset of Swedish breast cancer families, 162 families were screened for germline mutations in this gene. A combination of RT-PCR, PTT and direct DNA sequencing was used. Two mutations and one previously reported polymorphic variant resulting in a truncated protein were identified. Our data suggest that only a small proportion of Swedish breast cancer families is attributable to BRCA2 germline mutations. This result, in combination with the low frequency of BRCA1 germline mutations identified in our previous study, suggests additional high penetrant as well as low penetrant breast cancer susceptibility genes are involved in familial breast cancer.
引用
收藏
页码:134 / 139
页数:6
相关论文
共 50 条
  • [41] A breast/ovarian cancer patient with germline mutations in both BRCA1 and BRCA2
    Ramus, SJ
    Friedman, LS
    Gayther, SA
    Ponder, BAJ
    Bobrow, LG
    vanderLooji, M
    Papp, J
    Olah, E
    NATURE GENETICS, 1997, 15 (01) : 14 - 15
  • [42] BRCA1 and BRCA2 germline mutations in 85 Iranian breast cancer patients
    Keshavarzi, Fatemeh
    Javadi, Gholam Reza
    Zeinali, Sirous
    FAMILIAL CANCER, 2012, 11 (01) : 57 - 67
  • [43] Breast cancer risk for Korean women with germline mutations in BRCA1 and BRCA2
    Park, Boyoung
    Dowty, James G.
    Ahn, Choonghyun
    Win, Aung K.
    Kim, Sung-Won
    Lee, Min Hyuk
    Lee, Jong Won
    Kang, Eunyoung
    Hopper, John L.
    Park, Sue K.
    BREAST CANCER RESEARCH AND TREATMENT, 2015, 152 (03) : 659 - 665
  • [44] BRCA1 and BRCA2 germline mutations in Chinese Hakka breast cancer patients
    Zhang, Yinmei
    Wu, Heming
    Gan, Caiyan
    Rao, Hui
    Wang, Qiuming
    Guo, Xueming
    BMC MEDICAL GENOMICS, 2024, 17 (01)
  • [45] BRCA1 and BRCA2 germline mutations in 85 Iranian breast cancer patients
    Fatemeh Keshavarzi
    Gholam Reza Javadi
    Sirous Zeinali
    Familial Cancer, 2012, 11 : 57 - 67
  • [46] BRCA1 and BRCA2 germline mutations in Chinese Hakka breast cancer patients
    Yinmei Zhang
    Heming Wu
    Caiyan Gan
    Hui Rao
    Qiuming Wang
    Xueming Guo
    BMC Medical Genomics, 17
  • [47] Screening for germline rearrangements in BRCA1 and BRCA2 in Norwegian families with breast or breast/ovarian cancer
    Van Ghelue, M
    Ingebrigtsen, M
    Stensland, HMFR
    Mæhle, L
    Apold, J
    Moller, P
    Marton, V
    Jonsrud, C
    BREAST CANCER RESEARCH, 2005, 7 (Suppl 2) : S18 - S18
  • [48] Clinical relevance of ten BRCA1 and three BRCA2 intronic germline mutations in families with hereditary breast and/or ovarian cancer
    Wappenschmidt, B.
    Kohler, J.
    Bosse, K.
    Versmold, B.
    Schmutzler, R. K.
    ONKOLOGIE, 2008, 31 : 29 - 29
  • [49] Novel BRCA1 and BRCA2 germline mutations and assessment of mutation spectrum and prevalence in Italian breast and/or ovarian cancer families
    Giannini, Giuseppe
    Capalbo, Carlo
    Ristori, Elisabetta
    Ricevuto, Enrico
    Sidoni, Tina
    Buffone, Amelia
    Cortesi, Enrico
    Marchetti, Paolo
    Scambia, Giovanni
    Tomao, Silverio
    Rinaldi, Christian
    Zani, Massimo
    Ferraro, Sergio
    Frati, Luigi
    Screpanti, Isabella
    Gulino, Alberto
    BREAST CANCER RESEARCH AND TREATMENT, 2006, 100 (01) : 83 - 91
  • [50] BRCA1 and BRCA2 founder mutations account for 78% of germline carriers among hereditary breast cancer families in Chile
    Alvarez, Carolina
    Tapia, Teresa
    Perez-Moreno, Elisa
    Gajardo-Meneses, Patricia
    Ruiz, Catalina
    Rios, Mabel
    Missarelli, Claudio
    Silva, Mariela
    Cruz, Adolfo
    Matamala, Luis
    Carvajal-Carmona, Luis
    Camus, Mauricio
    Carvallo, Pilar
    ONCOTARGET, 2017, 8 (43) : 74233 - 74243